Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 5
1977 3
1981 1
1982 3
1983 5
1984 6
1985 5
1986 8
1987 7
1988 12
1989 10
1990 11
1991 10
1992 8
1993 9
1994 15
1995 15
1996 10
1997 16
1998 19
1999 20
2000 17
2001 14
2002 18
2003 10
2004 14
2005 10
2006 24
2007 20
2008 24
2009 21
2010 18
2011 25
2012 23
2013 28
2014 28
2015 27
2016 32
2017 29
2018 25
2019 22
2020 32
2021 36
2022 23
2023 24
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

695 results

Results by year

Filters applied: . Clear all
Page 1
Syphilis.
O'Byrne P, MacPherson P. O'Byrne P, et al. BMJ. 2019 Jun 28;365:l4159. doi: 10.1136/bmj.l4159. BMJ. 2019. PMID: 31253629 Free PMC article. No abstract available.
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. O'Byrne PM, et al. N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274. N Engl J Med. 2018. PMID: 29768149 Free article. Clinical Trial.
Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, Côté A, Davis BE, Leigh R, Myers I, O'Byrne PM, Sehmi R. Gauvreau GM, et al. Among authors: o byrne pm. Allergy. 2023 Feb;78(2):402-417. doi: 10.1111/all.15609. Epub 2022 Dec 14. Allergy. 2023. PMID: 36463491 Free PMC article. Review.
Development of an inhaled anti-TSLP therapy for asthma.
O'Byrne PM, Panettieri RA Jr, Taube C, Brindicci C, Fleming M, Altman P. O'Byrne PM, et al. Pulm Pharmacol Ther. 2023 Feb;78:102184. doi: 10.1016/j.pupt.2022.102184. Epub 2022 Dec 17. Pulm Pharmacol Ther. 2023. PMID: 36535465 Review.
Asthma remission.
O'Byrne PM. O'Byrne PM. J Bras Pneumol. 2024 Mar 22;50(1):e20240004. doi: 10.36416/1806-3756/e20240004. J Bras Pneumol. 2024. PMID: 38536985 Free PMC article. No abstract available.
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. Bateman ED, et al. Among authors: o byrne pm. N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275. N Engl J Med. 2018. PMID: 29768147 Free article. Clinical Trial.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Among authors: o byrne pm. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial.
695 results